Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CBD Medic is a consumer health brand specializing in over-the-counter (OTC) topical pain relief products that integrate hemp-derived cannabidiol (CBD) with active pharmaceutical ingredients like menthol and camphor. Originally developed by Abacus Health Products, the brand was acquired by Charlotte's Web Holdings in 2020 to expand its presence in the topical CBD market. Its product portfolio includes creams, ointments, and sprays targeted at indications such as arthritis, back and neck pain, and muscle soreness. The company's formulations are designed to provide localized relief by combining traditional analgesics with the purported benefits of cannabinoids. CBD Medic products are widely distributed through major retail pharmacy chains in the United States.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CBD Medic.